학술논문
85 - Results of a Phase II Study of Guadecitabine in Higher Risk MDS Patients Refractory to or Relapsing after Azacitidine Treatment.
Document Type
Abstract
Author
Source
Subject
*MYELODYSPLASTIC syndromes treatment
*AZACITIDINE
*MYELODYSPLASTIC syndromes
*PATIENTS
*THERAPEUTICS
*
*
*
*
Language
ISSN
0145-2126